Birmingham, AL, September 15, 2025
News Summary
Birmingham Capital Management Co. Inc. has reduced its stake in Pfizer Inc. by 6%, owning 163,243 shares after selling 10,344 shares in the recent quarter. This reduction now positions Pfizer as 1.6% of their investment portfolio. Conversely, other firms have been increasing their stakes in Pfizer, indicating diverse investor activity in the pharmaceutical giant’s stock amid recent price fluctuations.
Birmingham – Birmingham Capital Management Co. Inc. has decreased its holdings in Pfizer Inc. by 6.0% during the first quarter of the year. As of now, the firm owns 163,243 shares of Pfizer, following the sale of 10,344 shares during this period. This reduction places Pfizer as approximately 1.6% of Birmingham Capital Management’s investment portfolio, ranking it as the 24th largest investment for the firm.
The value of Birmingham Capital Management’s holdings in Pfizer was recorded at $4,137,000 at the conclusion of the most recent quarter. This adjustment comes amid various movements in investor activity surrounding Pfizer’s stock, with other firms increasing or establishing new stakes in the company.
For example, Gould Capital LLC significantly raised its stake in Pfizer by 97.2% in the fourth quarter, acquiring 1,000 shares valued at around $27,000 after purchasing 493 additional shares. Similarly, GKV Capital Management Co. Inc. entered into a new Pfizer position in the first quarter valued at approximately $27,000. Other firms like Bayforest Capital Ltd and North Capital Inc. also made new investments, each valued at around $28,000.
Significantly, institutional investors and hedge funds collectively own a substantial 68.36% of Pfizer’s stock, indicating a strong institutional presence in the company. This supportive investor behavior comes as Pfizer shares have seen fluctuations, trading down $0.95 to $23.91 during midday trading on a recent Friday. The trading volume for Pfizer shares surged to 81,158,118, far exceeding its average volume of 34,996,196.
Analyzing Pfizer’s performance metrics, the company’s current 50-day simple moving average stands at $24.79, while the 200-day simple moving average is at $24.28. Pfizer’s weeks and months have seen a twelve-month low of $20.92 and a high of $30.43. The firm retains a market capitalization of $135.94 billion and boasts a price-to-earnings ratio of 12.72.
In its latest quarterly earnings report published on August 5th, Pfizer demonstrated robust financial health, reporting an EPS of $0.78, surpassing analyst expectations by 20 cents. The company also achieved a revenue of $14.65 billion, which exceeded expectations and marked a 10.3% increase from the previous year. For fiscal year 2025, Pfizer has guided for an EPS range of 2.900-3.100, and analysts predict an EPS of 2.95 for the current fiscal year.
Investors received a recent quarterly dividend of $0.43 on September 2nd, 2025, resulting in an annualized dividend yield of 7.2%. Pfizer’s dividend payout ratio currently stands at 91.49%. The company has received varied recommendations from analysts, with two rating it a Strong Buy, four a Buy, eleven a Hold, and one a Sell, leading to a consensus rating of Hold and a target price of $28.12.
Analysts have adjusted their price targets for Pfizer, with HSBC lowering its target from $27.00 to $26.00 while keeping a buy rating. Meanwhile, firms like Jefferies Financial Group and Morgan Stanley have positively revised their targets to $33.00.
Overall, Pfizer continues to be a significant player in the pharmaceutical industry, developing, manufacturing, and marketing biopharmaceutical products across various therapeutic areas, including the well-known COVID-19 vaccine, Comirnaty.
FAQ
What did Birmingham Capital Management do with its Pfizer holdings?
Birmingham Capital Management reduced its stake in Pfizer by 6.0%, totaling 163,243 shares after selling 10,344 shares in the first quarter.
What were the recent trends in investor activity for Pfizer?
While Birmingham Capital Management reduced its stake, other firms like Gould Capital LLC increased theirs by 97.2%. Additionally, several institutions acquired new positions during the quarter.
How has Pfizer’s stock performed recently?
Pfizer shares traded down to $23.91, with significant variations in trading volume compared to averages. Its twelve-month high and low were $30.43 and $20.92, respectively.
What are Pfizer’s financial highlights from its latest earnings report?
Pfizer reported an EPS of $0.78, surpassing expectations by 20 cents, and revenue of $14.65 billion, indicating a 10.3% year-over-year increase.
Key Features of Pfizer’s Stock Activity
| Feature | Current Status | Comparison |
|---|---|---|
| Birmingham Capital Management Holdings | 163,243 shares | Reduced by 6.0% |
| Gould Capital LLC Holdings | 1,000 shares | Increased by 97.2% |
| Pfizer Share Price | $23.91 | Down $0.95 |
| Quarterly EPS | $0.78 | Exceeded by $0.20 |
| Quarterly Revenue | $14.65 billion | Increased by 10.3% YoY |
Deeper Dive: News & Info About This Topic
HERE Resources
Additional Resources
- MarketBeat
- Wikipedia: Pfizer
- Reuters
- Google Search: Pfizer
- The Conversation
- Encyclopedia Britannica: Pfizer Inc.
- BBC News
- Google News: Pfizer news
- Washingtonian
- Google Scholar: Pfizer
Author: STAFF HERE BIRMINGHAM WRITER
The BIRMINGHAM STAFF WRITER represents the experienced team at HEREBirmingham.com, your go-to source for actionable local news and information in Birmingham, Jefferson County, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as the Sidewalk Film Festival, Sloss Music & Arts Festival, Magic City Classic, and civil rights commemorations. Our coverage extends to key organizations like the Birmingham Business Alliance and the Birmingham Civil Rights Institute, plus leading businesses in healthcare, finance, and manufacturing that power the local economy such as UAB Medicine, Regions Bank, and Encompass Health. As part of the broader HERE network, including HEREHuntsville.com, we provide comprehensive, credible insights into Alabama's dynamic landscape.
